Showing results (391-400 of 418) with videos related to
Sort By:
Pageof 42
Pharmacotherapy|November 1, 1996
A pilot pharmacokinetic-pharmacodynamic study of benzodiazepine antagonism by flumazenil and aminophyllineM F Bonfiglio, L E Fisher-Katz, L M Saltis, et al.The Journal of Pharmacology and Experimental Therapeutics|April 1, 1993
Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activitiesD R Compton, K C Rice, B R De Costa, et al.British Journal of Pharmacology|April 26, 2000
O-1057, a potent water-soluble cannabinoid receptor agonist with antinociceptive propertiesR G Pertwee, T M Gibson, L A Stevenson, et al.British Journal of Pharmacology|January 25, 2007
The psychoactive plant cannabinoid, Delta9-tetrahydrocannabinol, is antagonized by Delta8- and Delta9-tetrahydrocannabivarin in mice in vivoR G Pertwee, A Thomas, L A Stevenson, et al.Drug and Alcohol Dependence|August 15, 2000
Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB(1) and CB(2) receptor bindingM M Aung, G Griffin, J W Huffman, et al.The Journal of Clinical Endocrinology and Metabolism|March 12, 2003
Racial differences in bone turnover and calcium metabolism in adolescent femalesR J Bryant, M E Wastney, B R Martin, et al.The Journal of Pharmacology and Experimental Therapeutics|August 17, 2000
Cannabinoid properties of methylfluorophosphonate analogsB R Martin, I Beletskaya, G Patrick, et al.Journal of Medicinal Chemistry|November 14, 1997
Synthesis and pharmacological comparison of dimethylheptyl and pentyl analogs of anandamideH H Seltzman, D N Fleming, B F Thomas, et al.British Journal of Pharmacology|May 14, 1999
An investigation into the structural determinants of cannabinoid receptor ligand efficacyG Griffin, E J Wray, W K Rorrer, et al.Journal of Medicinal Chemistry|September 30, 1994
Antipodal alpha-N-(methyl through decyl)-N-normetazocines (5,9 alpha-dimethyl-2'-hydroxy-6,7-benzomorphans): in vitro and in vivo propertiesE L May, M D Aceto, E R Bowman, et al.Pageof 42